2-ETHYNYLTETRAHYDROFURAN, 95%, 250mg

2-(Trifluoromethyl)benzoic acid, 98.0%, 100g

2,3-Dibromobenzoic acid, 95.0%, 250mg

Obiettivo IOS E-Plan fase EPLPHi 10x/0,25 corretto all'infinito. Distanza di lavoro 5,95 mm

monoclonale murino anti-Strep-tag, C23.21, 100 µg

TERT-BUTYL 3-AMINO-2,2-DIMETHYLPROPANOATE, 95%, 1g

1-(3,5-Dimethylphenyl)-2,2,2-trifluoroethan-1-ol, 97%, 1g

1,3,6-Trimethyl-1 H -pyrazolo[3,4- b ]pyridine-4-carboxylic acid, 95.0%, 5g

(3R,4R)-tert-Butyl 3-amino-4-methylpyrrolidine-1-carboxylate, 95.0%, 500mg

2,4-Dichloropyridin-3-ol, 95.0%, 1g

2-(9H-Carbazol-9-yl)ethanol, 95.0%, 10g

1-(BENZO[D]THIAZOL-2-YL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 250mg

3-Bromo-2-(chloromethyl)-5-methylpyridine, 98%, 500mg